Talen Energy Corp
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
TLN$361.18-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
| (Millions of Dollars, except share data) | September 30,2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Cash and cash equivalents | $335 | $689 |
| Restricted cash and cash equivalents (Note 16) | 14 | 63 |
| Accounts receivable (Note 3) | 304 | 196 |
| Inventory, net (Note 5) | 316 | 278 |
| Derivative instruments (Notes 2 and 11) | 122 | 56 |
| Other current assets | 61 | 67 |
| Total current assets | 1,152 | 1,349 |
| Property, plant and equipment, net (Note 7) | 11,858 | 7,546 |
| Nuclear decommissioning trust funds (Notes 6 and 11) | 1,976 | 1,900 |
| Derivative instruments (Notes 2 and 11) | 9 | 4 |
| Other noncurrent assets | 92 | 106 |
| Total Assets | $15,087 | $10,905 |
| Liabilities and Equity | ||
| Long-term debt, due within one year (Notes 10 and 11) | $29 | $29 |
| Accrued interest | 169 | 60 |
| Accounts payable and other accrued liabilities | 391 | 281 |
| Derivative instruments (Notes 2 and 11) | 617 | 101 |
| Stock-based compensation liabilities (Note 13) | 2 | 501 |
| Other current liabilities | 82 | 78 |
| Total current liabilities | 1,290 | 1,050 |
| Long-term debt (Notes 10 and 11) | 9,540 | 6,782 |
| Derivative instruments (Notes 2 and 11) | 243 | 67 |
| Postretirement benefit obligations (Note 12) | 203 | 229 |
| Asset retirement obligations and accrued environmental costs (Note 8) | 500 | 494 |
| Deferred income taxes | 938 | 486 |
| Acquired contract liabilities (Note 17) | 734 | 662 |
| Other noncurrent liabilities | 36 | 42 |
| Total Liabilities | $13,484 | $9,812 |
| Commitments and Contingencies (Note 9) | ||
| Stockholders' Equity (Note 15) | ||
| Common stock ($0.001 par value, 350,000,000 shares authorized) (a) | $— | $— |
| Additional paid-in capital | 2,562 | 1,709 |
| Accumulated retained earnings (deficit) | (947) | (612) |
| Accumulated other comprehensive income (loss) | (35) | (4) |
| Total Stockholders' Equity | 1,580 | 1,093 |
| Noncontrolling interests | 23 | — |
| Total Equity | 1,603 | 1,093 |
| Total Liabilities and Stockholders' Equity | $15,087 | $10,905 |
(a)47,316,772 and 45,687,828 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.